PRIMARY STUDY
Cannabinoids-Induced Rhabdomyolysis in a Patient: A Report of a Case and a Review of Literature
Key Findings: This case report of a 48-year-old patient with bladder cancer who developed rhabdomyolysis, the leading theory was that it was related to a synthetic medical cannabis product he was taking, possibly via G-protein coupled receptor activation.
Type of Study: Meta-analysis
Study Sample Size: 1
Study Result: Negative
Research Location(s): Saudi Arabia
Year of Pub: 2025
Cannabinoids Studied: Tetrahydrocannabinol (THC), Synthetic Cannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
Receptors Studied: GPCR
Citation: AlKhateeb S, Albulushi B, Joueidi K, Joueidi F. Cannabinoids-Induced Rhabdomyolysis in a Patient: A Report of a Case and a Review of Literature. Cureus. 2025 Mar 19;17(3):e80809. doi: 10.7759/cureus.80809. PMID: 40255777; PMCID: PMC12006958.
